Efficacy of catheter-based renal denervation in mongrel neurogenic hypertensive dogs

Chinese Journal of Cardiology

Volumn 40, Issue 1, 2012, Pages 14-17

  Lu, Cheng Zhi ^a   Liu, Jia ^a   Xia, Da Sheng ^a   Zhao, Xiang Dong ^a   Chen, Xin ^a   Yu, Xiang ^a   Xu, Jian Qiang ^a   Zhang, Jing ^a   Pan, Li ^a   Liu, Shao Ying ^a   Wang, Li ^a  

^a TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

Catheter ablation; Denervation; Hypertension

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; CREATININE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATHETER; CONTROLLED STUDY; DOG; HYPERTENSION; KIDNEY DENERVATION; MEAN ARTERIAL PRESSURE; NONHUMAN;

ANIMALS; CATHETER ABLATION; DOGS; HYPERTENSION; KIDNEY; SYMPATHECTOMY;

EID: 84862070756     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2012.01.004     Document Type: Article

References (18)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation, 2010, 121: e259.
2. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet, 2005, 65: 217-223.
3. 2011, 17: 207.
4. Jordan J. Sympathetic genes, baroreflexes, and hypertension. Clin Auton Res, 2004, 14: 369-375.
5. Grisk O, Rettig R. Interactions between the sympathetic nervous system and the kidneys in arterial hypertension. Cardiovasc Res, 2004, 61: 238-246.
6. Grassi G, Arenare F, Pieruzzi F, et al. Sympathetic activation in cardiovascular and renal disease. J Nephrol, 2009, 22: 190-195.
7. Smith PA, Graham LN, Mackintosh AF, et al. Relationship between central sympathetic activity and stages of human hypertension. Am J Hypertens, 2004, 17: 217-222.
8. Crimson KS. Total thoracic andpartial to total lumbar sympathectomy and celiac ganglionectomy in the treatment of hypertension. Ann Surg, 1941, 114: 753-775.
9. Knepper PA, Neudorff LG, Et A. Hypertension: surgical treatment by transthoracic thoracolumbar sympathectomy. Mo Med, 1949, 46: 855-860.
10. Li M, Galligan J, Wang D, et al. The effects of celiac ganglionectomy on sympathetic innervation to the splanchnic organs in the rat. Auton Neurosci, 2010, 154: 66-73.
11. King AJ, Osborn JW, Fink GD. Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats. Hypertension, 2007, 50: 547-556.
12. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet, 2009, 373: 1275-1281.
13. Levy EI, Scarrow AM, Jannetta PJ. Microvascular decompression in the treatment of hypertension: review and update. Surg Neurol, 2001, 55: 2-10.
14. Segal R. Microvascular decompression of the left lateral medulla oblongata for severe refractory neurogenic hypertension. Neurosurgery, 1999, 44: 232-233.
15. Doumas M, Faselis C, Papademetriou V. Renal sympathetic denervation and systemic hypertension. Am J Cardiol, 2010, 105: 570-576.
16. Schlaich MP, Sobotka PA, Krum H, et al. Renal sympathetic nerveablation for uncontrolled hypertension. N Engl J Med, 2009, 361: 932-934.
17. Schlaich MP, Sobotka PA, Krum H, et al. Renal denervation as a therapeutic approach for hypertension: Novel implications for an old concept. Hypertension, 2009, 54: 1195-1201.
18. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension, 2011, 57: 911-917.